Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sema Calis

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Biomedical Nanotechnology|July 7, 2012
A novel protein-based anticancer drug encapsulating nanosphere: apoferritin-doxorubicin complexMehmet A Kilic, Erdal Ozlu, Sema Calis
International Journal of Pharmaceutics|January 24, 2021
Antibody-mediated drug deliveryFatma Betul Arslan, Kivilcim Ozturk Atar, Sema Calis
Drug Development and Industrial Pharmacy|April 28, 2006
Formulation and in vitro evaluation of bisphosphonate loaded microspheres for implantation in osteolysisSibel Samdancioglu, Sema Calis, Murat Sumnu, et al.
International Journal of Pharmaceutics|February 9, 2020
Aggregation of chitosan nanoparticles in cell culture: Reasons and resolutionsKivilcim Ozturk, Fatma Betul Arslan, Ece Tavukcuoglu, et al.
Pharmaceutics|January 21, 2023
Effects of Particle Geometry for PLGA-Based Nanoparticles: Preparation and In Vitro/In Vivo EvaluationMeryem Kaplan, Kıvılcım Öztürk, Süleyman Can Öztürk, et al.
Acta Pharmaceutica (Zagreb, Croatia)|February 11, 2004
5-Fluorouracil in topical liposome gels for anticancer treatment--formulation and evaluationMarija Glavas-Dodov, Emilija Fredro-Kumbaradzi, Katerina Goracinova, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|December 17, 2013
Comparative biodistribution studies of technetium-99 m radiolabeled amphiphilic nanoparticles using three different reducing agents during the labeling procedureNikola Geskovski, Sonja Kuzmanovska, Maja Simonoska Crcarevska, et al.
Molecular Pharmaceutics|February 27, 2018
Tumor-Induced Myeloid Cells Are Reduced by Gemcitabine-Loaded PAMAM Dendrimers Decorated with Anti-Flt1 AntibodyDigdem Yoyen-Ermis, Kivilcim Ozturk, M Alper Kursunel, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Biomedical Nanotechnology|July 7, 2012
A novel protein-based anticancer drug encapsulating nanosphere: apoferritin-doxorubicin complexMehmet A Kilic, Erdal Ozlu, Sema Calis
International Journal of Pharmaceutics|January 24, 2021
Antibody-mediated drug deliveryFatma Betul Arslan, Kivilcim Ozturk Atar, Sema Calis
Drug Development and Industrial Pharmacy|April 28, 2006
Formulation and in vitro evaluation of bisphosphonate loaded microspheres for implantation in osteolysisSibel Samdancioglu, Sema Calis, Murat Sumnu, et al.
International Journal of Pharmaceutics|February 9, 2020
Aggregation of chitosan nanoparticles in cell culture: Reasons and resolutionsKivilcim Ozturk, Fatma Betul Arslan, Ece Tavukcuoglu, et al.
Pharmaceutics|January 21, 2023
Effects of Particle Geometry for PLGA-Based Nanoparticles: Preparation and In Vitro/In Vivo EvaluationMeryem Kaplan, Kıvılcım Öztürk, Süleyman Can Öztürk, et al.
Acta Pharmaceutica (Zagreb, Croatia)|February 11, 2004
5-Fluorouracil in topical liposome gels for anticancer treatment--formulation and evaluationMarija Glavas-Dodov, Emilija Fredro-Kumbaradzi, Katerina Goracinova, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|December 17, 2013
Comparative biodistribution studies of technetium-99 m radiolabeled amphiphilic nanoparticles using three different reducing agents during the labeling procedureNikola Geskovski, Sonja Kuzmanovska, Maja Simonoska Crcarevska, et al.
Molecular Pharmaceutics|February 27, 2018
Tumor-Induced Myeloid Cells Are Reduced by Gemcitabine-Loaded PAMAM Dendrimers Decorated with Anti-Flt1 AntibodyDigdem Yoyen-Ermis, Kivilcim Ozturk, M Alper Kursunel, et al.
Pageof 1